India to Myanmar: Imipenem Export Trade Route
India has recorded 52 verified shipments of Imipenem exported to Myanmar, representing a combined trade value of $2.0M USD. This corridor is served by 23 active Indian exporters, with an average shipment value of $38.7K USD. The leading Indian exporter is M J BIOPHARM PRIVATE LIMITED, which accounts for 33% of total export value with 6 shipments worth $664.9K USD. On the buying side, LIFELINE CO LIMITED is the largest importer in Myanmar with $582.8K USD in purchases. The top 3 suppliers — M J BIOPHARM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD — together control 72% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Myanmar Imipenem corridor is one of India's established pharmaceutical export routes, with 52 shipments documented worth a combined $2.0M USD. The route is dominated by M J BIOPHARM PRIVATE LIMITED, which alone accounts for roughly 33% of all export value, reflecting the consolidated nature of India's imipenem manufacturing sector.
Across 23 active suppliers, the average shipment value stands at $38.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with imipenem's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 25.1%, placing it at rank #12 among India's top imipenem export destinations globally.
On the import side, key buyers of Indian imipenem in Myanmar include LIFELINE CO LIMITED, M/S. JDS CO., LTD., M/S. JDS CO. LTD. and 31 others. LIFELINE CO LIMITED is the single largest importer with 4 shipments valued at $582.8K USD.
Route Characteristics
- Average transit28 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#12
- Annual growth+25.1%
- Demand growth+23.0%
- Regulatory ease82/100
Top 10 Indian Imipenem Exporters to Myanmar
Showing top 10 of 23 Indian suppliers exporting Imipenem to Myanmar, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | M J BIOPHARM PRIVATE LIMITED Avg $110.8K per shipment | 6 | $664.9K | 33.1% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $67.6K per shipment | 9 | $608.8K | 30.3% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $90.8K per shipment | 2 | $181.6K | 9.0% |
| 4 | ADVANOV PHARMA PRIVATE LIMITED Avg $22.6K per shipment | 4 | $90.5K | 4.5% |
| 5 | VIDA LABORATORIES PRIVATE LIMITED Avg $17.4K per shipment | 5 | $86.9K | 4.3% |
| 6 | M. J. BIOPHARM PRIVATE LIMITED Avg $38.6K per shipment | 2 | $77.3K | 3.8% |
| 7 | VIDA LABORATORIES PRIVATE LIMITED Avg $21.1K per shipment | 3 | $63.4K | 3.2% |
| 8 | BRAWN LABORATORIES LIMITED Avg $36.5K per shipment | 1 | $36.5K | 1.8% |
| 9 | SRS PHARMACEUTICALS PRIVATE LIMITED Avg $35.5K per shipment | 1 | $35.5K | 1.8% |
| 10 | PANGENE BIOTECH LTD Avg $16.2K per shipment | 2 | $32.4K | 1.6% |
This table shows the top 10 of 23 Indian companies exporting imipenem to Myanmar, ranked by total trade value. The listed exporters are: M J BIOPHARM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, ADVANOV PHARMA PRIVATE LIMITED, VIDA LABORATORIES PRIVATE LIMITED, M. J. BIOPHARM PRIVATE LIMITED , VIDA LABORATORIES PRIVATE LIMITED , BRAWN LABORATORIES LIMITED, SRS PHARMACEUTICALS PRIVATE LIMITED , PANGENE BIOTECH LTD. M J BIOPHARM PRIVATE LIMITED is the dominant supplier with 6 shipments worth $664.9K USD, giving it a 33% market share. The top 3 suppliers together account for 72% of the total trade value on this route.
Showing top 10 of 23 total Indian exporters on the India to Myanmar Imipenem export route.
Top 10 Imipenem Importers in Myanmar
Showing top 10 of 34 known buyers in Myanmar receiving Imipenem shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian imipenem in Myanmar include LIFELINE CO LIMITED, M/S. JDS CO., LTD., M/S. JDS CO. LTD., JDS CO LIMITED, JDS CO LTD, among 34 total buyers. The largest importer is LIFELINE CO LIMITED, accounting for $582.8K USD across 4 shipments — representing 29% of all imipenem imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LIFELINE CO LIMITED | 4 | $582.8K | 29.0% |
| 2 | M/S. JDS CO., LTD. | 3 | $255.7K | 12.7% |
| 3 | M/S. JDS CO. LTD. | 2 | $117.7K | 5.9% |
| 4 | JDS CO LIMITED | 1 | $91.9K | 4.6% |
| 5 | JDS CO LTD | 1 | $91.2K | 4.5% |
| 6 | HEALTHCARE MANDALAR PHARMACEUTICALS | 4 | $90.5K | 4.5% |
| 7 | MS JDS CO LTD | 1 | $90.3K | 4.5% |
| 8 | LIFELINE CO LTD | 2 | $82.1K | 4.1% |
| 9 | LIFELINE CO, LTD, | 2 | $77.3K | 3.8% |
| 10 | MS JDS CO LIMITED | 1 | $72.7K | 3.6% |
Showing top 10 of 34 Imipenem importers in Myanmar on this route.
Top 10 Imipenem Formulations Imported by Myanmar
Showing top 10 of 45 product formulations shipped on the India to Myanmar Imipenem route, ranked by trade value
Myanmar imports a wide range of imipenem formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PANTIN 500 MG IMIPENEM & CILASTATIN FOR — accounts for $485.9K USD across 2 shipments. There are 45 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PANTIN 500 MG IMIPENEM & CILASTATIN FOR | 2 | $485.9K | 24.2% |
| 2 | BACQURE INJECTION 500MG PACK : 1 Vial Batch : DFG1535D EACH VIAL CONTAINS IMIPENEM PH, EUR/USP (STERILE) EQUIVALENT TO | 2 | $211.6K | 10.5% |
| 3 | BACQURE INJ.500MG EACH VIAL CONT IMIPENEM PH EUR/USPSTERILEEQ.TO ANHYDROUS IMIPENEM 500MG CILASTATIN SODIUM PH.EUR/USP | 2 | $183.2K | 9.1% |
| 4 | PANTIN 500 MG IMIPENEM & CILASTATIN FORINJECTION USP 500MG] 30000 PACKS OF 1X500MG | 1 | $96.9K | 4.8% |
| 5 | BACQURE INJECTION 500MG PACK: 1 Vial BATCH: DFE3914A, DFE5089A EACH VIAL CONT.:IMIPENEM PH.EUR/USP STERILE EQ.TO ANHY | 1 | $90.3K | 4.5% |
| 6 | PANTIN 500 MG IMIPENEM AND CILASTATIN FOR INJECTION USP 500 MG 25500 PACKS OF1X500MG | 1 | $82.1K | 4.1% |
| 7 | PANTIN 500 MG (IMIPENEM AND CILASTATIN F | 2 | $77.3K | 3.8% |
| 8 | BACQURE INJECTION 500MG PACK : 1 Vial Batch : DFE5089A EACH VIAL CONTS IMIPENEMPH EUR/USP STERILE EQ TO ANHYDROUS IM | 1 | $72.7K | 3.6% |
| 9 | BACQURE INJECTION 500MG PACK: 1 Vial BATCH: DFG0150A EACH VIAL CONT. IMIPENEM PH.EUR/USP (STERILE) EQ.TO ANHYDROUS IMIPE | 1 | $64.1K | 3.2% |
| 10 | IMIDEX (IMIPENEM 500MG & CILASTATIN 500M | 3 | $63.4K | 3.2% |
Showing top 10 of 45 Imipenem formulations imported by Myanmar on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 5 shipments. Transit time averages 28 days by sea.
Market Dynamics
India's imipenem exports to Myanmar are driven primarily by a handful of large-scale manufacturers. M J BIOPHARM PRIVATE LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 23 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — M J BIOPHARM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD — together account for 72% of total trade value on this route. The average shipment value of $38.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as bacqure injection 500mg pack : 1 vial batch : dfg1535d each vial contains imipenem ph, eur/usp (sterile) equivalent to and bacqure inj.500mg each vial cont imipenem ph eur/uspsterileeq.to anhydrous imipenem 500mg cilastatin sodium ph.eur/usp, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, LIFELINE CO LIMITED is the largest importer with 4 shipments worth $582.8K USD — representing 29% of all imipenem imports from India on this route. A total of 34 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.0M
- Avg. Shipment
- $38.7K
- Suppliers
- 23
- Buyers
- 34
- Transit (Sea)
- ~28 days
- Annual Growth
- +25.1%
Other Imipenem Routes
Unlock the Full India to Myanmar Imipenem Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 52 shipments on this route.
Frequently Asked Questions — India to Myanmar Imipenem Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Imipenem to Myanmar?
The leading Indian exporters of Imipenem to Myanmar are M J BIOPHARM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD. M J BIOPHARM PRIVATE LIMITED holds the largest market share at approximately 33% of total trade value on this route.
Q What is the total value of Imipenem exports from India to Myanmar?
India exports Imipenem to Myanmar worth approximately $2.0M USD across 52 recorded shipments. The average value per shipment is $38.7K USD.
Q Which ports does India use to ship Imipenem to Myanmar?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 5 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Myanmar for Imipenem?
The average transit time for Imipenem shipments from India to Myanmar is approximately 28 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Myanmar Imipenem trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.1% with demand growth tracking at 23.0%. The route is ranked #12 among India's top Imipenem export destinations globally.
Q How many suppliers are active on the India to Myanmar Imipenem route?
There are currently 23 active Indian suppliers exporting Imipenem to Myanmar. The market is moderately concentrated with M J BIOPHARM PRIVATE LIMITED accounting for 33% of total shipment value.
Q Who are the main importers of Imipenem from India in Myanmar?
The leading importers of Indian Imipenem in Myanmar include LIFELINE CO LIMITED, M/S. JDS CO., LTD., M/S. JDS CO. LTD., JDS CO LIMITED, JDS CO LTD. LIFELINE CO LIMITED is the largest buyer with 4 shipments worth $582.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Myanmar export trade corridor identified from Indian Customs (DGFT) records for Imipenem.
- 2.Supplier/Buyer Matching: 23 Indian exporters and 34 importers in Myanmar matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 52 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
52 Verified Shipments
23 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists